Sign in with Google. Opens in new tab

Shanghai Haohai Biological Technology (688366CH)- Diversified Business Layout Doesn't Secure Outlook

375 Views19 May 2022 00:43
Haohai builds diversified business via M&A,but none is growth point with high certainty. Its medical aesthetics has no obvious advantage and the valuation would be lower due to centralized procurement
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
x